S&P Futures
6,002.25 -1.50 (-0.02%) Dow Futures
43,897.00 -13.00 (-0.03%) Nasdaq Futures
21,222.25 -2.50 (-0.01%) Russell 2000 Futures
2,397.00 +1.30 (+0.05%) Crude Oil
71.93 -0.43 (-0.59%) Gold
2,704.10 -1.70 (-0.06%)
Lumos Pharma, Inc. (LUMO)
After hours:
| Previous Close | 4.3100 |
| Open | 4.3100 |
| Bid | 4.2800 x 100 |
| Ask | 4.3700 x 100 |
| Day's Range | 4.3100 - 4.4050 |
| 52 Week Range | 1.3700 - 4.5800 |
| Volume | |
| Avg. Volume | 99,242 |
| Market Cap | 37.404M |
| Beta (5Y Monthly) | 0.33 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.4400 |
| Earnings Date | Nov 07, 2024 - Nov 11, 2024 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 9.69 |
GlobeNewswireLumos Pharma Announces Two Abstracts Accepted for Oral Presentation at the 62ⁿᵈ Annual ESPE Meeting 2024
AUSTIN, Texas, Oct. 30, 2024 (GLOBE NEWSWIRE) -- Lumos Pharma (NASDAQ:LUMO), a clinical stage biopharmaceutical company focused on therapeutics for rare diseases, announced today that updated analyses of data from the Company’s Phase 2 OraGrowtH210 and OraGrowtH212 clinical trials have been accepted for oral presentation at the 62nd Annual European Society for Paediatric Endocrinology Meeting, or ESPE 2024, to be held November 16-18, 2024 in Liverpool, UK. Two abstracts on data from the OraGrowt
Simply Wall St.Discover Smart Share Global Among 2 Other Prominent US Penny Stocks
Major U.S. stock indexes recently experienced mixed performance, with the Dow Jones and S&P 500 on track to end their six-week winning streaks amid a backdrop of critical economic data and earnings reports. In such a fluctuating market, identifying stocks that offer potential growth opportunities is key, especially when considering investments in smaller or newer companies often categorized as penny stocks. Despite being an outdated term, penny stocks still represent intriguing possibilities...
